A Descriptive Study of Children with Idiopathic Thrombocytopenic Purpura (ITP) Referred to Ahvaz Shafa Hospital from 2010 to 2018

Authors

1 ASSISTANT PROFESSOR OF PEDIATRIC HEMATOLOGY AND ONCOLOGY

2 Assistant Professor of Pediatrics.Department of Pediatrics, Abuzar Children & Rsquo;s Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

3 Medical Student.Medical Student, Jundishapur University of Medical Sience, Ahvaz, Iran.

4 Assistant Professor of Epidemiology and Biostatistics.Department of Epidemiology and Biostatistics, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Abstract

Background and Objectie: Idiopathic thrombocytopenic purpura (ITP) is the most common cause of acute thrombocytopenia in children, which usually occurs following common viral infections and rarely lead to severe and life-threatening bleeding. The aim of this study was to evaluate the demographic characteristics and the incidence of ITP among children admitted to Ahwaz Shafa Hospital from 2010 to 2018.
Subjects and Methods: The present study is a descriptive retrospective epidemiological study. The files of ITP patients admitted to Ahvaz Shafa Hospital from 2010 to 2018 were reviewed. Necessary information was collected including age, sex, acute or chronic form of ITP and incidence and the season of occurrence. Data were analyzed by SPSS software.
Results: The medical records of 5128 cases related to patients admitted to Ahvaz Shafa Hospital due to hematological problems were reviewed, of which 997 patients were diagnosed with ITP (19.44%). Out of 997 patients with ITP, 446 (44.7%) were girls and 551 (55.3%) were boys. 790 patients (79.23%) were less than 7 years old. 898 patients (90.1%) had acute ITP and 99 patients (9.9%) had chronic ITP. 275 patients (27.6%) were infected in Spring, 206 patients (20.7%) in Summer, 269 patients (27%) in Autumn and 247 patients (24.8%) in Winter.
Conclusion: The highest incidence of ITP among patients admitted to Ahvaz Shafa Hospital were age under 7 yr, male acute disease and the highest prevalence was in Spring.

Keywords


 
1-Hatzistilianou M, Janoudaki M, Massaad M, Geha R, Kanariou M. Idiopathic Thrombocytopenic Purpura. Springer; 2019.
2-Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. J Am Soci Hematol. 2009;113(26):6511-21.
3-Cines DB, McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med. 2005;56(2):425-42.
4-Glanz J, France E, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatr. 2008;121(3):e506-e12.
5-Bansal D, Bhamare TA, Trehan A, Ahluwalia J, Varma N, Marwaha R. Outcome of chronic idiopathic thrombocytopenic purpura in children. Pediatr Blood Cancer. 2010;54(3):403-7.
6-Sutor AH, Harms A, Kaufmehl K, editors. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Seminars in thrombosis and hemostasis; 2001.
7-Michel M. Immune thrombocytopenic purpura: epidemiology and implications for patients. Europ J Haematol. 2009;82(2):3-7.
8-Marieke Schoonen W, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, et al. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol. 2009;145(2):235-44.
9-Yong M, Schoonen WM, Li L, Kanas G, Coalson J, Mowat F, et al. Epidemiology of paediatric immune thrombocytopenia in the General Practice Research Database. Br J Haematol. 2010;149(6):855-64.
10-Zeller B, Rajantie J, HedlundÔÇÉTreutiger I, Tedgård U, Wesenberg F, Jonsson OG, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr. 2005;94(2):178-84.
11-Al-Mulla N, Bener A, Amer A, Abu Laban M. Idiopathic thrombocytopenic purpura in childhood: a population-based study in Qatar. J Pediatr. 2009;85(3):269-72.
12-Landgren O, Gridley G, Fears TR, Caporaso N. Immune thrombocytopenic purpura does not exhibit a disparity in prevalence between African American and white veterans. Blood. 2006;108(3):1111-2.
13-Terrell DR, Johnson KK, Vesely SK, George JN. Is immune thrombocytopenic purpura less common among black Americans? Blood. 2005;105(3):1368-9.
14-Youinou P, Pers J-O, Gershwin ME, Shoenfeld Y. Geoepidemiology and autoimmunity. Elsevier; 2010.
15-Stiakaki E, Perdikogianni C, Thomou C, Markaki EA,Katzilakis N, Tsirigotaki M, et al.Idiopathic thrombocytopenic purpura in childhood: twenty years of experience in a single center. Pediatr Int. 2012;54(4):524-7.
16-Motiei H, Alipour M, Karimi HR. Evaluation of clinical and laboratory symptoms and treatment in patients with idiopathic thrombocytopenic purpura admitted to Qods Hospital in Qazvin from April 1997 to 2001. Qazvin Qazvin University Of Medical Sience; 2003.
17-Kühne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Berchtold W, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr. 2003;143(5):605-8.
18-Hedman A, Henter JI, Hedlund I, Elinder G. Prevalence and treatment of chronic idiopathic thrombocytopenic purpura of childhood in Sweden. Acta Paediatr. 1997;86(2):226-7.
19-Aronis S, Platokouki H, Mitsika A, Haidas S, Constantopoulos A. Seventeen years of experience with chronic idlopathlc thrombocytopenic purpura in childhood. Is therapy always better? Pediatr Hematol Oncol. 1994;11(5):487-98.
20-Wong MS-C, Chan GC-F, Ha SY, Lau Y-L. Clinical characteristics of chronic idiopathic thrombocytopenia in Chinese children. J Pediatr Hematol Oncol. 2002;24(8):648-52.
21-Kühne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet. 2001;358(9299):2122-5.
22-Yetgin S, Olcay L, Özsoylu ┼×, Hiçsönmez G, Gürgey A, Tuncer AM. Retrospective analysis of 78 children with chronic idiopathic thrombocytopenic purpura: follow-up from 1976 to 1996. Pediatr Hematol Oncol. 1997;14(5):399-412.
23-Robb L, Tiedeman K. Idiopathic thrombocytopenic purpura: predictors of chronic disease. Arch Dis Childhoo. 1990;65(5):502-6.
24-Bolton-Maggs P, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet. 1997;350(9078):620-3.